Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8305975

EMD:Ref Document

Bid Value: Ref Document

61 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8294730

EMD:Ref Document

Bid Value: Ref Document

61 Days Left

U S Army Space And Missile Defense Command Usasmdc Space And Missile Defense Technical Center Smdtc Broad Agency Announcement For Science Technology And Test And Evaluation Research

Deadline: 26 Aug 2029

United States

Ref. No.: 8265596

EMD:Ref Document

Bid Value: Ref Document

1173 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8238031

EMD:Ref Document

Bid Value: Ref Document

204 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8229694

EMD:Ref Document

Bid Value: Ref Document

204 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8222586

EMD:Ref Document

Bid Value: Ref Document

204 Days Left

Prequalification Pool Public Private Partnerships P3 Consulting Service

Deadline: 21 Jun 2027

United States

Ref. No.: 8208564

EMD:Ref Document

Bid Value: Ref Document

376 Days Left

United States Army Research Institute For The Behavioral And Social Sciences Ari Broad Agency Announcement For Basic Applied And Advanced Scientific Research

Deadline: 30 Apr 2028

United States

Ref. No.: 8189860

EMD:Ref Document

Bid Value: Ref Document

690 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8162291

EMD:Ref Document

Bid Value: Ref Document

204 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 8140990

EMD:Ref Document

Bid Value: Ref Document

367 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Somatropin Genotropin

Deadline: 10 Aug 2026

Germany

Ref. No.: 8099325

EMD:Ref Document

Bid Value: Ref Document

61 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Trastuzumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8091920

EMD:Ref Document

Bid Value: Ref Document

61 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 8084923

EMD:Ref Document

Bid Value: Ref Document

367 Days Left

Medicines Containing The Active Ingredient Dapagliflozin Atc A10Bk01

Deadline: 31 Jul 2026

Germany

Ref. No.: 8054393

EMD:Ref Document

Bid Value: Ref Document

51 Days Left

Pharmaceutical Discount Agreements Pursuant To Section 130A Para 8 Sgb V Within The Framework Of Open House Procedures

Deadline: 06 Jul 2026

Germany

Ref. No.: 8023646

EMD:Ref Document

Bid Value: Ref Document

26 Days Left

Discover Tenders by Profile Sections Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Profile Sections Sector

Filter Your Search

FREE Trial plan for all new users!